Javascript must be enabled to continue!
Primary Care Physicians’ Perceptions Concerning Engagement in Cancer Survivor Care
View through CrossRef
Abstract
PurposeGiven the growing diversity among cancer survivors and the fact that oncologists typically do not perform long-term care, the expected role of primary care physicians (PCPs) in cancer survivor care is expanding. However, communication and collaboration between oncologists and PCPs is lacking. Therefore, we assessed the perception of cancer survivor care among PCPs.MethodsWe surveyed 767 Japanese Board-certified PCPs, regardless of facility type (clinics and hospitals), inquiring about PCPs’ perceptions of their role in survivor care. Additionally, we included vignette-based scenarios focused on colorectal and prostate cancer survivors to explore factors associated with their clinical decisions. Results We obtained 91 replies (response rate: 11.9%). A total of 75% of PCPs had encountered at least 1 cancer patient in actual practice. Even for patients actively receiving cancer treatment, >70% of PCPs reported that they were willing to engage in all aspects of survivor care, except for the administration of anticancer drugs. Further, 49% of PCPs considered that both PCPs and oncologists were suited to performing regular screening for cancer recurrence in high-risk patients. Multivariable logistic regression analyses revealed that clinic PCPs were less inclined to conduct screening for recurrence than hospital PCPs in both colorectal (odds ratio, 3.85 [95% confidence interval 1.40-10.6]) and prostate cancer (4.36 [95% confidence interval 1.51-12.6]) scenarios.ConclusionsOur findings suggest that Japanese PCPs are willing to engage in survivor care and encourage closer collaboration between oncologists and PCPs. However, oncologists might need to request cooperation, considering the facility type with which PCPs are affiliated.
Title: Primary Care Physicians’ Perceptions Concerning Engagement in Cancer Survivor Care
Description:
Abstract
PurposeGiven the growing diversity among cancer survivors and the fact that oncologists typically do not perform long-term care, the expected role of primary care physicians (PCPs) in cancer survivor care is expanding.
However, communication and collaboration between oncologists and PCPs is lacking.
Therefore, we assessed the perception of cancer survivor care among PCPs.
MethodsWe surveyed 767 Japanese Board-certified PCPs, regardless of facility type (clinics and hospitals), inquiring about PCPs’ perceptions of their role in survivor care.
Additionally, we included vignette-based scenarios focused on colorectal and prostate cancer survivors to explore factors associated with their clinical decisions.
Results We obtained 91 replies (response rate: 11.
9%).
A total of 75% of PCPs had encountered at least 1 cancer patient in actual practice.
Even for patients actively receiving cancer treatment, >70% of PCPs reported that they were willing to engage in all aspects of survivor care, except for the administration of anticancer drugs.
Further, 49% of PCPs considered that both PCPs and oncologists were suited to performing regular screening for cancer recurrence in high-risk patients.
Multivariable logistic regression analyses revealed that clinic PCPs were less inclined to conduct screening for recurrence than hospital PCPs in both colorectal (odds ratio, 3.
85 [95% confidence interval 1.
40-10.
6]) and prostate cancer (4.
36 [95% confidence interval 1.
51-12.
6]) scenarios.
ConclusionsOur findings suggest that Japanese PCPs are willing to engage in survivor care and encourage closer collaboration between oncologists and PCPs.
However, oncologists might need to request cooperation, considering the facility type with which PCPs are affiliated.
Related Results
Pregnant Prisoners in Shackles
Pregnant Prisoners in Shackles
Photo by niu niu on Unsplash
ABSTRACT
Shackling prisoners has been implemented as standard procedure when transporting prisoners in labor and during childbirth. This procedure ensu...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Ultrasonographic severity scoring of non-immune hydrops: a predictor of perinatal mortality
Ultrasonographic severity scoring of non-immune hydrops: a predictor of perinatal mortality
Abstract
Aim: To develop an ultrasonographic severity scoring of non-immune hydrops in order to predict perinatal outcomes in women with non-immun...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose:
To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
GP CanShare - Enhancing Cancer Management in Primary Care with integrated cancer care
GP CanShare - Enhancing Cancer Management in Primary Care with integrated cancer care
Who? Cancer impacts many peoples’ lives. The number of people living with and beyond, a cancer diagnosis is increasing significantly and they are faced with complex decisions, with...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
A study of clinical characteristics and risk factors of mortality associated with tigecycline
A study of clinical characteristics and risk factors of mortality associated with tigecycline
Abstract
Background: Tigecycline has a broad spectrum of antimicrobial activity and become more widely used. However, in 2010, the FDA warned that tigecycline was associate...

